Xtant Medical Forecast, price target & analysts
Xtant Medical Target price 2026 - Analyst rating & recommendation
Xtant Medical Classifications & Recommendation
Xtant Medical Price Target
| Target Price | $1.02 |
| Price | $0.32 |
| Potential |
217.76%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Xtant Medical 2027 .
The average Xtant Medical target price is $1.02.
This is
217.76%
register free of charge
$1.58
390.65%
register free of charge
$0.61
88.79%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Xtant Medical to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Xtant Medical stock has an average upside potential 2027 of
217.76%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 133.93 | 101.50 |
| 14.21% | 24.21% | |
| EBITDA Margin | 9.34% | -3.11% |
| 239.54% | 133.30% | |
| Net Margin | 3.71% | -15.97% |
| 126.45% | 530.35% |
5 Analysts have issued a sales forecast Xtant Medical 2026 . The average Xtant Medical sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Xtant Medical EBITDA forecast 2026. The average Xtant Medical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Xtant Medical Analysts have issued a net profit forecast 2026. The average Xtant Medical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.03 | -0.12 |
| 125.00% | 500.00% | |
| P/E | negative | |
| EV/Sales | 0.66 |
5 Analysts have issued a Xtant Medical forecast for earnings per share. The average Xtant Medical EPS is
This results in the following potential growth metrics and future valuations:
Current Xtant Medical Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| LUCID CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Sep 02 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | May 13 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Mar 31 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Nov 11 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
LUCID CAPITAL MARKETS:
Locked
➜
Locked
|
Sep 02 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
May 13 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Mar 31 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Nov 11 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
